Austin, TX, United States of America

Savara Inc.

Calculating rank
USPTO Granted Patents = 5

% Expired Patents = 100.0



Forward Citations = 6

Loading Chart...
Loading Chart...

6 inventors (with patents filed for the assignee):

goldMedal Mei-chang Kuo (3 out of 56 patents)

silverMedal John Lord (3 out of 11 patents)

bronzeMedal Jaakko Taneli Jouhikainen (3 out of 3 patents)

4.  Herman E Snyder (3 out of 4 patents)

5.  Pravin L Soni (3 out of 36 patents)

6.  Alan Bruce Montgomery (2 out of 27 patents)

7.  Uwe Hetzer (16 patents)

8.  Stefan Seemann (2 patents)

9.  Pravin Soni (0 patent)

10.  Mei-Chang Kuo (0 patent)

11.  Markus Tservistas (0 patent)


5 patents:

Company Overview
Savara Inc. is a clinical-stage specialty pharmaceutical company focused on the development and commercialization of novel therapies for serious and rare respiratory diseases. The company's lead product candidate, Molgradex, is being developed for the treatment of autoimmune pulmonary alveolar proteinosis (aPAP). Savara is also developing an investigational drug, AeroVanc, for the treatment of MRSA lung infection in patients with cystic fibrosis.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 17 2026

5 Patents

#497 in Austin, TX

#3,340 in Texas

#51,743 in US

Austin, TX (US)
Austin, TX, United States of America
Forward Citations = 6

6 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Savara Inc.. Retrieved from https://idiyas.com/company/savara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…